Citations

Clear

7551 citation(s) found for "Ho, Matthew".

Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center
Modest, Mara C., García, Joaquín J. , Arndt, Carola, Carlson, Matthew L. , Arndt, Carola S

Mayo Clinic

The Laryngoscope | November 4, 2015 | Volume: 126 | Issue: 8 | Pages: 1899-1904

10.1002/lary.25773 | PMID 26535795 Get It

Objectives/HypothesisEvaluate presentation, management, and clinical outcomes of patients with temporal bone Langerhans cell histiocytosis (LCH).Study DesignRetrospective chart review.MethodsReviewed all patients with temporal bone LCH at a tertiary academic referral center between 1978 and 2014. Presentation, disease course, intervention, and clinical outcomes were analyzed.ResultsBetween 1978 and 2014, 29 temporal bones in 20 patients (12 males; median age 32 years, range 1.3–88 years) were diagnosed with temporal bone LCH, representing 4% of all patients diagnosed with LCH at our institution during that time. Twelve (60%) patients presented purely with head and neck disease, nine (45%) with bilateral temporal bone involvement, seven (35%) with intracranial spread, and eight (40%) with multisystem disease. The most common presenting symptoms were otorrhea (n = 11; 55%) and subjective hearing loss (n = 10; 50%). Treatment included primary chemotherapy or radiation alone(n = 7; 35%), local resection alone (n = 2; 10%), and chemotherapy or radiation with surgery(n = 11; 55%). Ten patients suffered local or systemic relapse (50%; median 12 months). Median follow‐up for patients was 31 months. One patient died secondary to pulmonary complications of multisystem LCH.ConclusionsLCH is an uncommon histiocytic disorder with a range of clinical manifestations and disease severity. Otologic involvement is rare, and frequently manifests with symptoms similar to otomastoiditis. Evaluation and close follow‐up of both ears is important. Bilateral simultaneous or sequential LCH can be seen in up to 45% of cases. Patients with temporal bone LCH should be managed by a multidisciplinary team with treatment tailored to the patient. Relapse is more common in patients with multisystem involvement. Even in subjects with isolated otologic involvement, long‐term follow‐up is critical, with relapses occurring years beyond treatment.Level of Evidence4. Laryngoscope, 126:1899–1904, 2016
The Impact of Prior Radiation Therapy on Artificial Urinary Sphincter Device Survival
Rivera, Marcelino , Linder, Brian J. , Ziegelmann, Matthew , Viers, Boyd R. , Rangel, Laureano J. , Elliott, Daniel S. , Rivera, Marcelino E, Ziegelmann, Matthew J, Linder, Brian J , Viers, Boyd R

Mayo Clinic

Journal of Urology | October 30, 2015 | Volume: 195 | Issue: 4 Part 1 | Pages: 1033-1037

10.1016/j.juro.2015.10.119 | PMID 26518111 Get It

Embolisation of an iatrogenic pulmonary artery pseudoaneurysm
Petersen, Matthew G., Brinegar, Katelyn N., Öklü, Rahmi , Oklu, Rahmi

Mayo Clinic

BMJ Case Reports | October 29, 2015 | Volume: 2015 | Issue: No issue available | Pages: bcr2015212555

10.1136/bcr-2015-212555 | PMID 26516252 Get It

A 62-year-old woman with idiopathic cardiomyopathy and class IIIB/stage C heart failure sustained right pulmonary artery injury from a Swan-Ganz catheter during a pretransplant work up. Postprocedure, it was noted that the patient's segmental pulmonary artery catheter was wedged for an unclear period of time. The patient developed a small volume of blood-tinged sputum and a chest CT revealed a 1.3 cm pseudoaneurysm in the right middle lobe medial segment pulmonary artery and a small area of haemorrhage. The patient underwent pulmonary artery preserving coil embolisation of the pseudoaneurysm to prevent further right heart strain, given an ejection fraction of 20%, which resolved haemoptysis. Imaging studies showed preserved distal outflow and no evidence of residual pseudoaneurysm filling.
Characterization of material properties of soft solid thin layers with acoustic radiation force and wave propagation
Nenadic, Ivan , Qiang, Bo, Chen, Shigao , Greenleaf, James F. , Urban, Matthew W. , Nenadic, Ivan Z, Bernal, Miguel

Mayo Clinic

The Journal of the Acoustical Society of America | October 28, 2015 | Volume: 138 | Issue: 4 | Pages: 2499-2507

10.1121/1.4932170 | PMID 26520332 Get It

Evaluation of tissue engineering constructs is performed by a series of different tests. In many cases it is important to match the mechanical properties of these constructs to those of native tissues. However, many mechanical testing methods are destructive in nature which increases cost for evaluation because of the need for additional samples reserved for these assessments. A wave propagation method is proposed for characterizing the shear elasticity of thin layers bounded by a rigid substrate and fluid-loading, similar to the configuration for many tissue engineering applications. An analytic wave propagation model was derived for this configuration and compared against finite element model simulations and numerical solutions from the software package Disperse. The results from the different models found very good agreement. Experiments were performed in tissue-mimicking gelatin phantoms with thicknesses of 1 and 4 mm and found that the wave propagation method could resolve the shear modulus with very good accuracy, no more than 4.10% error. This method could be used in tissue engineering applications to monitor tissue engineering construct maturation with a nondestructive wave propagation method to evaluate the shear modulus of a material.
Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study
Miller, Virginia M. , Jenkins, Gregory D. , Heit, John A. , Huggins, Gordon S. , Hodis, Howard N., Budoff, Matthew J. , Løbo, Rogerio A. , Taylor, Hugh S. , Black, Dennis M. , Harman, S. Mitchell , de Andrade, Mariza, Biernacka, Joanna M. , Manson, JoAnn E. , Naftolin, Frederick , Andrade, Mariza de , Budoff, Matthew

Mayo Clinic

Physiological Genomics | October 28, 2015 | Volume: 48 | Issue: 1 | Pages: 33-41

10.1152/physiolgenomics.00029.2015 | PMID 26508701 Get It

Prior to the initiation of menopausal hormone treatment (MHT), genetic variations in the innate immunity pathway were found to be associated with carotid artery intima-medial thickness (CIMT) and coronary arterial calcification (CAC) in women ( n = 606) enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Whether MHT might affect these associations is unknown. The association of treatment outcomes with variation in the same 764 candidate genes was evaluated in the same KEEPS participants 4 yr after randomization to either oral conjugated equine estrogens (0.45 mg/day), transdermal 17β-estradiol (50 μg/day), each with progesterone (200 mg/day) for 12 days each month, or placebo pills and patch. Twenty SNPs within the innate immunity pathway most related with CIMT after 4 yr were not among those associated with CIMT prior to MHT. In 403 women who completed the study in their assigned treatment group, single nucleotide polymorphisms (SNPs) within the innate immunity pathway were found to alter the treatment effect on 4 yr change in CIMT (i.e., significant interaction between treatment and genetic variation in the innate immunity pathway; P < 0.001). No SNPs by treatment effects were observed with changes of CAC >5 Agatston units after 4 yr. Results of this study suggest that hormonal status may interact with genetic variants to influence cardiovascular phenotypes, specifically, the pharmacogenomic effects within the innate immunity pathway for CIMT.
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database
Renfro, Lindsay A. , Loupakis, Fotios , Adams, Richard , Seymour, Michel , Heinemann, Volker , Douillard, Jean‐Yves , Hurwitz, Herbert I. , Fuchs, Charles S. , Díaz‐Rubio, Eduardo , Porschen, Rainer, Tournigand, Christophe , Chibaudel, Benoist , Falcone, Alfredo , Punt, Cornelis J.A. , Hecht, J. Randolph , Bokemeyer, Carsten , Goldberg, Richard M. , Saltz, Leonard B. , Gramont, Aimery de , Lenz, Heinz‐Josef , Adams, Richard A, Seymour, Matthew T, Schmoll, Hans‐Joachim , Hurwitz, Herbert, Díaz-Rubio, Eduardo, Tebbutt, Niall C. , van Cutsem, Eric, de Gramont, Aimery, Cutsem, Eric Van , Sargent, Daniel J. , Saltz, Leonard , Falcone, Alfredo , Seymour, Matthew T , Adams, Richard , Chibaudel, Benoist

Mayo Clinic

Journal of Clinical Oncology | October 26, 2015 | Volume: 34 | Issue: 2 | Pages: 144-150

10.1200/jco.2015.61.6441 | PMID 26503203 Get It

Purpose In recent retrospective analyses of early-stage colorectal cancer (CRC), low and high body mass index (BMI) scores were associated with worsened outcomes. Whether BMI is a prognostic or predictive factor in metastatic CRC (mCRC) is unclear. Patients and Methods Individual data from 21,149 patients enrolled onto 25 first-line mCRC trials during 1997 to 2012 were pooled. We assessed both prognostic and predictive effects of BMI on overall survival and progression-free survival, and we accounted for patient and tumor characteristics and therapy type (targeted v nontargeted). Results BMI was prognostic for overall survival (P < .001) and progression-free survival (P < .001), with an L-shaped pattern. That is, risk of progression and/or death was greatest for low BMI; risk decreased as BMI increased to approximately 28 kg/m 2 , and then it plateaued. Relative to obese patients, patients with a BMI of 18.5 kg/m 2 had a 27% increased risk of having a PFS event (95% CI, 20% to 34%) and a 50% increased risk of death (95% CI, 43% to 56%). Low BMI was associated with poorer survival for men than women (interaction P < .001). BMI was not predictive of treatment effect. Conclusion Low BMI is associated with an increased risk of progression and death among the patients enrolled on the mCRC trials, with no increased risk for elevated BMI, in contrast to the adjuvant setting. Possible explanations include negative effects related to cancer cachexia in patients with low BMI, increased drug delivery or selection bias in patients with high BMI, and potential for an interaction between BMI and molecular signaling pathways.
All‐Inside Posterior Cruciate Ligament Reconstruction: GraftLink Technique
Prince, Matthew, King, Alexander H. , Sousa, Paul L., Levy, Bruce A. , Prince, Matthew R, Stuart, Michael J.

Mayo Clinic

Arthroscopy Techniques | October 26, 2015 | Volume: 4 | Issue: 5 | Pages: No page available

10.1016/j.eats.2015.06.009 | PMID 26900564 Get It

Abstract Posterior cruciate ligament (PCL) injuries account for nearly 20% of knee ligament injuries. PCL injuries can occur in isolation or, more commonly, in the setting of multiligamentous knee injuries. Isolated PCL disruptions are commonly treated nonoperatively; however, symptomatic grade III injuries, as well as PCL injuries found in multiligamentous injuries, are frequently treated surgically. Several reconstructive techniques exist for the treatment of PCL deficiency without a clear optimal approach. We describe our preferred operative technique to reconstruct the PCL using an all‐inside arthroscopic approach with a quadrupled tibialis anterior or peroneus longus allograft with both tibial and femoral suspensory fixation. Technique Video video See video under supplementary data.
Atrial fibrillation, cognitive impairment, and neuroimaging
Graff‐Radford, Jonathan , Madhavan, Malini , Vemuri, Prashanthi , Cha, Ruth H., Mielke, Michelle M. , Kantarci, Kejal , Lowe, Val J. , Senjem, Matthew L. , Gunter, Jeffrey L. , Petersen, Ronald C. , Jack, Clifford R. , Roberts, Rosebud O., Rabinstein, Alejandro A. , Cha, Ruth H., Knopman, David S. , Jack, Clifford R , Mielke, Michelle M , Vemuri, Prashanthi , Senjem, Matthew L , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | October 25, 2015 | Volume: 12 | Issue: 4 | Pages: 391-398

10.1016/j.jalz.2015.08.164 | PMID 26607820 Get It

AbstractIntroductionThe objective of our study was to investigate cross‐sectional associations of atrial fibrillation with neuroimaging measures of cerebrovascular disease and Alzheimer's disease and their interactions with mild cognitive impairment (MCI).MethodsMagnetic resonance imaging scans of individuals from a population‐based study were analyzed for infarctions, total gray matter, and hippocampal and white matter hyperintensity volumes. A subsample underwent positron emission tomography imaging.ResultsAtrial fibrillation was associated with infarctions and lower total gray matter volume. Compared with subjects with no atrial fibrillation and no infarction, the odds ratio (95% confidence intervals) for MCI was 2.99 (1.57–5.70; P = .001) among participants with atrial fibrillation and infarction, 0.90 (0.45–1.80; P = .77) for atrial fibrillation and no infarction, and 1.50 (0.96–2.34; P = .08) for no atrial fibrillation and any infarction.DiscussionParticipants with both atrial fibrillation and infarction are more likely to have MCI than participants with either infarction or atrial fibrillation alone.
Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie’s Disease
Ziegelmann, Matthew , Viers, Boyd R. , McAlvany, Kelly L., Bailey, George C., Savage, Joshua B., Trost, Landon , Ziegelmann, Matthew J, Trost, Landon W, Viers, Boyd R

Mayo Clinic

Journal of Urology | October 25, 2015 | Volume: 195 | Issue: 4 Part 1 | Pages: 1051-1056

10.1016/j.juro.2015.10.065 | PMID 26476353 Get It

Artificial Urinary Sphincter Mechanical Failures—Is it Better to Replace the Entire Device or Just the Malfunctioning Component?
Linder, Brian J. , Viers, Boyd R. , Ziegelmann, Matthew , Rivera, Marcelino , Rangel, Laureano J. , Elliott, Daniel S. , Ziegelmann, Matthew J, Rivera, Marcelino E, Linder, Brian J , Viers, Boyd R

Mayo Clinic

Journal of Urology | October 23, 2015 | Volume: 195 | Issue: 5 | Pages: 1523-1528

10.1016/j.juro.2015.10.084 | PMID 26493494 Get It